Evidence-Based Prescribing of Common Mental Health Medication

1 day
(Up to 35 delegates)

This is in-house training – we come to your organisation and deliver to your staff on an agreed date at a venue chosen and arranged by you. All participants will receive training materials and certificates of attendance.

The Course Aim
1 in 4 people will experience some kind of mental health problem in any one year with mixed anxiety and depression being the most common. Insomnia has been reported approximately 1 in 6 of adults being more common in women, older people and those with concurrent physical or mental health conditions. During the day we will explore common mental health presentations and the drugs used to treat them.

Learning outcomes
By the end of the session participants should be able to:
• Discuss the prevalence of common mental health conditions in the UK
• Understand the BNF drug groups used to treat mental health conditions and their basic pharmacology
• Understand the basics of evidence-base medicine (EBM) and how to apply this to prescribing mental health medication using relevant clinical guidelines and diagnostic tools
• Describe the importance of drug interactions associated with mental-health medication and how to apply this to your practice

Course content
• Overview of the impact and prevalence of mental health conditions in the UK
• What are the basic BNF drug groups and how do they work?
• What is EBM and why is it important when prescribing drugs to treat mental health conditions?
• What do the current guidelines advise about prescribing common mental health medication?
• What diagnostic tools are available to support me as an NMP and how do I use them?
• How relevant are drug interactions to me and my patient?

Our trainer Graham Parsons, has been a pharmacist for 22 years and has an interest in Mental Health specialising in Substance Use disorders. In 2003 Graham was invited to work alongside a GP Specialist in Substance Misuse and undertook the RCGP Certificate in the Management of Substance Misuse (Parts I and II) and a Diploma in Community Pharmacy at Cardiff University. Graham joined NHS Plymouth in 2005 as a specialist medicines management advisor in substance misuse. In April 2007 Graham became an NMP and in July 2010 was appointed to the Advisory Council on the Misuse of Drugs. He currently works in the NEW Devon CCG Clinical Effectiveness and Medicines Optimisation Team advising clinicians on evidence-based prescribing.